Effects of antilipolytic agents on glucose utilization by adipose tissue.
D000273:Adipose Tissue / Q000378:metabolism*; D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D004822:Epididymis / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009539:Nicotinic Acids / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D002247:Carbon Isotopes; D007328:Insulin; D009539:Nicotinic Acids; D011720:Pyrazoles; D002245:Carbon Dioxide; D005947:Glucose; D009638:Norepinephrine